Free cash flow (half year)
Net operating cash flow minus capital expenditures.
Unit million EUR Industry Pharmaceuticals
Records
1
Regions
1
Period
2026
Sources
1
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Free cash flow (half year)
Global, as of 30 Jun 2026
3,724 million EUR
Source: Sanofi · CC BY 4.0 · statorigin.org
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| Global 1 record | |||
| as of 30 Jun 2026 | 3,724 million EUR | Sanofi · 30 Jul 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded | Sanofi | 30 Jul 2026 | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Free cash flow (half year). Retrieved from https://statorigin.org/indicators/free-cash-flow-half-year